,trastuzumab deruxtecan
astrazeneca,daiichi sankyo
['destiny,breast,4', 'breast', 'destiny-breast04']
1. access to journals &amp; therefore knowledge can be inequitable given lack of universal open access. in the spirit of this years asco of advancing equitable cancer care through innovation i m tweeting the figures of the landmark destiny-breast04 study. #asco2022 
Professor of Translational Oncology and Consultant Medical Oncologist